GKOS Glaukos | $98.34
-5.6% | 7/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 7/14/2025 |
KIDS OrthoPediatrics | $22.00
-0.6% | 7/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of OrthoPediatrics (NASDAQ:KIDS) on 7/14/2025 |
VAL Valaris | $46.70
-3.6% | 7/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Valaris (NYSE:VAL) on 7/14/2025 |
SYK Stryker | $390.80
-0.2% | 7/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 7/14/2025 |
ORGO Organogenesis | $4.03
-10.2% | 7/15/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 7/15/2025 |
BFH Bread Financial | $60.06
-3.1% | 7/14/2025 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $105.00 | Low | View details for BTIG Research rating of Bread Financial (NYSE:BFH) on 7/14/2025 |
MASI Masimo | $160.04
-1.0% | 7/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Medium | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 7/14/2025 |
ALC Alcon | $86.04
-1.5% | 7/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $100.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 7/14/2025 |
ISRG Intuitive Surgical | $512.23
-0.8% | 7/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $566.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 7/14/2025 |
OM Outset Medical | $18.08
-3.9% | 7/14/2025 | Target Set by | BTIG Research | Analyst Marie Thibault | Buy -> Buy | $37.00 | High | View details for BTIG Research rating of Outset Medical (NASDAQ:OM) on 7/14/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
AXP American Express | $310.67
-3.2% | 7/14/2025 | Target Set by | BTIG Research | Analyst V. Caintic | Sell -> Sell | $277.00 | Low | View details for BTIG Research rating of American Express (NYSE:AXP) on 7/14/2025 |
TDW Tidewater | $48.72
-3.3% | 7/14/2025 | Downgraded by | BTIG Research | Analyst Gregory Lewis | Buy -> Neutral | | Medium | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 7/14/2025 |
FTI TechnipFMC | $34.19
-0.3% | 7/14/2025 | Downgraded by | BTIG Research | Analyst Greg Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of TechnipFMC (NYSE:FTI) on 7/14/2025 |
PRG Aaron's | $28.21
-3.2% | 7/14/2025 | Downgraded by | BTIG Research | Analyst Vincent Ciantic | Neutral -> Sell | $24.00 | Low | View details for BTIG Research rating of Aaron’s (NYSE:PRG) on 7/14/2025 |
BORR Borr Drilling | $1.94
-1.1% | 7/14/2025 | Downgraded by | BTIG Research | Analyst Greg Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of Borr Drilling (NYSE:BORR) on 7/14/2025 |
AFRM Affirm | $66.15
+3.3% | 7/14/2025 | Downgraded by | BTIG Research | Analyst Vincent Caintic | Buy -> Neutral | | High | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 7/14/2025 |
SYF Synchrony Financial | $68.60
-3.2% | 7/14/2025 | Upgraded by | BTIG Research | Analyst Vincent Caintic | Neutral -> Buy | $100.00 | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 7/14/2025 |
ALLY Ally Financial | $39.06
-3.9% | 7/14/2025 | Upgraded by | BTIG Research | Analyst V. Caintic | Sell -> Neutral | | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 7/14/2025 |
BFH Bread Financial | $60.06
-3.1% | 7/14/2025 | Target Set by | BTIG Research | Analyst Vincent Caintic | Neutral -> Buy | $105.00 | High | View details for BTIG Research rating of Bread Financial (NYSE:BFH) on 7/14/2025 |
ZS Zscaler | $288.90
-0.8% | 7/10/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 7/10/2025 |
MDT Medtronic | $89.26
-0.5% | 7/11/2025 | Reiterated by | BTIG Research | - | Neutral -> Neutral | | Low | View details for BTIG Research rating of Medtronic (NYSE:MDT) on 7/11/2025 |
SGHC Super Group (SGHC) | $11.50
-1.3% | 7/8/2025 | Reiterated by | BTIG Research | Analyst C. Lampen | Buy -> Buy | | Medium | View details for BTIG Research rating of Super Group (SGHC) (NYSE:SGHC) on 7/8/2025 |
VRNA Verona Pharma PLC American Depositary Share | $104.77
+0.1% | 7/10/2025 | Downgraded by | BTIG Research | Analyst Thomas Shrader | Strong-Buy -> Hold | | Low | View details for BTIG Research rating of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) on 7/10/2025 |
RXST RxSight | $7.45
-3.7% | 7/9/2025 | Reiterated by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of RxSight (NASDAQ:RXST) on 7/9/2025 |
AIRO AIRO Group | $27.46
-2.9% | 7/8/2025 | Initiated by | BTIG Research | Analyst Andre Madrid | Buy | $26.00 | Low | View details for BTIG Research rating of AIRO Group (NASDAQ:AIRO) on 7/8/2025 |
CORZ Core Scientific | $13.76
+1.5% | 7/7/2025 | Downgraded by | BTIG Research | Analyst Gregory Lewis | Strong-Buy -> Hold | $20.00 | High | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 7/7/2025 |
CYRX CryoPort | $7.33
-2.3% | 7/7/2025 | Target Lowered by | BTIG Research | Analyst David Larsen | Buy -> Buy | $13.00 -> $10.00 | High | View details for BTIG Research rating of CryoPort (NASDAQ:CYRX) on 7/7/2025 |
SLP Simulations Plus | $12.97
-25.8% | 7/7/2025 | Target Lowered by | BTIG Research | Analyst David Larsen | Buy -> Buy | $41.00 -> $25.00 | High | View details for BTIG Research rating of Simulations Plus (NASDAQ:SLP) on 7/7/2025 |
JSPR Jasper Therapeutics | $3.31
-4.6% | 7/7/2025 | Target Lowered by | BTIG Research | Analyst Justin Zelin | Buy -> Buy | $64.00 -> $20.00 | Medium | View details for BTIG Research rating of Jasper Therapeutics (NASDAQ:JSPR) on 7/7/2025 |
APGE Apogee Therapeutics | $37.14
-4.5% | 7/7/2025 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $115.00 | Medium | View details for BTIG Research rating of Apogee Therapeutics (NASDAQ:APGE) on 7/7/2025 |
DASH DoorDash | $236.77
-2.5% | 7/1/2025 | Target Raised by | BTIG Research | Analyst Jake Fuller | Buy -> Buy | $225.00 -> $265.00 | High | View details for BTIG Research rating of DoorDash (NASDAQ:DASH) on 7/1/2025 |
RBLX Roblox | $112.38
+0.5% | 7/1/2025 | Target Raised by | BTIG Research | Analyst Clark Lampen | Buy -> Buy | $73.00 -> $124.00 | High | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 7/1/2025 |
SSSS SURO Capital | $8.42
-0.4% | 7/1/2025 | Target Set by | BTIG Research | Analyst Marvin Fong | Buy -> Buy | $7.00 -> $10.00 | Low | View details for BTIG Research rating of SURO Capital (NASDAQ:SSSS) on 7/1/2025 |
INMB INmune Bio | $2.07
-2.4% | 7/1/2025 | Reiterated by | BTIG Research | Analyst Thomas Shrader | Buy -> Neutral | | Medium | View details for BTIG Research rating of INmune Bio (NASDAQ:INMB) on 7/1/2025 |
MCW Mister Car Wash | $6.41
-2.7% | 6/30/2025 | Initiated by | BTIG Research | Analyst M. Fong | Neutral | | Medium | View details for BTIG Research rating of Mister Car Wash (NYSE:MCW) on 6/30/2025 |
DRVN Driven Brands | $17.25
-2.7% | 6/30/2025 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $22.00 | Medium | View details for BTIG Research rating of Driven Brands (NASDAQ:DRVN) on 6/30/2025 |
TBPH Theravance Biopharma | $11.53
+0.5% | 6/27/2025 | Target Raised by | BTIG Research | Analyst Julian Harrison | Buy -> Buy | $24.00 -> $25.00 | High | View details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 6/27/2025 |
COMP Compass | $6.49
-2.7% | 6/27/2025 | Upgraded by | BTIG Research | Analyst J. Fuller | Buy | $9.00 | Medium | View details for BTIG Research rating of Compass (NYSE:COMP) on 6/27/2025 |
NFE New Fortress Energy | $3.76
-3.3% | 6/26/2025 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | Low | View details for BTIG Research rating of New Fortress Energy (NASDAQ:NFE) on 6/26/2025 |
KYMR Kymera Therapeutics | $44.91
+0.0% | 6/26/2025 | Reiterated by | BTIG Research | Analyst Jeet Mukherjee | Buy -> Buy | $59.00 | Low | View details for BTIG Research rating of Kymera Therapeutics (NASDAQ:KYMR) on 6/26/2025 |
[ATTENTION] This Crypto Rocket Is About Launch… (Ad) Every crypto bull market ends with a final surge — the window where fortunes are made fast.
According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
HPP Hudson Pacific Properties | $2.77
-2.8% | 6/25/2025 | Target Lowered by | BTIG Research | Analyst Thomas Catherwood | Buy -> Buy | $8.00 -> $4.75 | Medium | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 6/25/2025 |
SMR NuScale Power | $42.90
+1.9% | 6/25/2025 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of NuScale Power (NYSE:SMR) on 6/25/2025 |
NKTR Nektar Therapeutics | $23.80
-2.5% | 6/24/2025 | Target Raised by | BTIG Research | - | Buy | $60.00 -> $100.00 | High | View details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 6/24/2025 |
AVAV AeroVironment | $263.89
-0.4% | 6/24/2025 | Target Raised by | BTIG Research | Analyst Andre Madrid | Buy -> Buy | $225.00 -> $300.00 | High | View details for BTIG Research rating of AeroVironment (NASDAQ:AVAV) on 6/24/2025 |
CBLL CeriBell | $15.73
-4.0% | 6/24/2025 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $30.00 | Medium | View details for BTIG Research rating of CeriBell (NASDAQ:CBLL) on 6/24/2025 |
LFMD LifeMD | $10.94
-3.4% | 6/18/2025 | Target Raised by | BTIG Research | - | Buy -> Buy | $15.00 -> $18.00 | Medium | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 6/18/2025 |
HCAT Health Catalyst | $3.74
-3.1% | 6/17/2025 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | Medium | View details for BTIG Research rating of Health Catalyst (NASDAQ:HCAT) on 6/17/2025 |
CLSK Cleanspark | $12.19
-3.3% | 6/13/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Cleanspark (NASDAQ:CLSK) on 6/13/2025 |
JILL J.Jill | $14.64
-3.7% | 6/11/2025 | Target Set by | BTIG Research | Analyst Janine Stichter | Buy -> Buy | $30.00 | Low | View details for BTIG Research rating of J.Jill (NYSE:JILL) on 6/11/2025 |
CURV Torrid | $2.80
-4.6% | 6/12/2025 | Initiated by | BTIG Research | Analyst T. Shrader | Neutral | | High | View details for BTIG Research rating of Torrid (NYSE:CURV) on 6/12/2025 |
HROW Harrow | $34.37
-3.5% | 6/12/2025 | Initiated by | BTIG Research | Analyst T. Shrader | Buy | $62.00 | Low | View details for BTIG Research rating of Harrow (NASDAQ:HROW) on 6/12/2025 |
WING Wingstop | $317.66
-0.2% | 6/11/2025 | Target Raised by | BTIG Research | - | Buy | $350.00 -> $430.00 | High | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 6/11/2025 |
GTLB GitLab | $42.90
+0.8% | 6/11/2025 | Target Lowered by | BTIG Research | Analyst Gary Powell | Buy -> Buy | $86.00 -> $67.00 | High | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 6/11/2025 |
SGHC Super Group (SGHC) | $11.50
-1.3% | 6/11/2025 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $9.00 -> $11.00 | Low | View details for BTIG Research rating of Super Group (SGHC) (NYSE:SGHC) on 6/11/2025 |
LULU lululemon athletica | $222.19
-2.9% | 6/6/2025 | Target Lowered by | BTIG Research | Analyst Janine Stichter | Buy -> Buy | $420.00 -> $405.00 | High | View details for BTIG Research rating of lululemon athletica (NASDAQ:LULU) on 6/6/2025 |
ZS Zscaler | $288.90
-0.8% | 6/4/2025 | Target Raised by | BTIG Research | Analyst Gray Powell | Buy -> Buy | $298.00 -> $329.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 6/4/2025 |
SHAK Shake Shack | $137.07
-2.1% | 6/2/2025 | Downgraded by | BTIG Research | Analyst Peter Saleh | Buy -> Neutral | | Medium | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 6/2/2025 |
DOCS Doximity | $61.64
+0.1% | 6/2/2025 | Upgraded by | BTIG Research | Analyst David Larsen | Neutral -> Buy | $80.00 | High | View details for BTIG Research rating of Doximity (NASDAQ:DOCS) on 6/2/2025 |
LQDA Liquidia Technologies | $14.51
+0.2% | 5/27/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Liquidia Technologies (NASDAQ:LQDA) on 5/27/2025 |
GLNG Golar LNG | $40.48
-1.4% | 5/28/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 5/28/2025 |
ABNB Airbnb | $136.54
-1.5% | 5/28/2025 | Reiterated by | BTIG Research | - | Neutral -> Neutral | | Low | View details for BTIG Research rating of Airbnb (NASDAQ:ABNB) on 5/28/2025 |
ATI ATI | $89.98
-0.7% | 5/28/2025 | Target Set by | BTIG Research | Analyst Andre Madrid | Buy -> Buy | $105.00 | Medium | View details for BTIG Research rating of ATI (NYSE:ATI) on 5/28/2025 |
GMED Globus Medical | $55.86
-2.6% | 5/27/2025 | Reiterated by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Neutral | | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 5/27/2025 |
CHEF Chefs' Warehouse | $64.06
-2.6% | 5/23/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Chefs’ Warehouse (NASDAQ:CHEF) on 5/23/2025 |
EMBC Embecta | $9.58
-7.6% | 5/23/2025 | Target Set by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $25.00 | High | View details for BTIG Research rating of Embecta (NASDAQ:EMBC) on 5/23/2025 |
ORKA Oruka Therapeutics | $14.25
-3.1% | 5/22/2025 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | | High | View details for BTIG Research rating of Oruka Therapeutics (NASDAQ:ORKA) on 5/22/2025 |
CLYM Climb Bio | $1.37
-3.5% | 5/22/2025 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | | Medium | View details for BTIG Research rating of Climb Bio (NASDAQ:CLYM) on 5/22/2025 |
SNOW Snowflake | $212.78
-0.3% | 5/22/2025 | Reiterated by | BTIG Research | Analyst G. Powell | Buy -> Buy | | Medium | View details for BTIG Research rating of Snowflake (NYSE:SNOW) on 5/22/2025 |
CRWD CrowdStrike | $473.28
-0.6% | 5/22/2025 | Reiterated by | BTIG Research | Analyst G. Powell | Buy -> Buy | | High | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 5/22/2025 |
OKTA Okta | $91.10
-0.9% | 5/22/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 5/22/2025 |
ORKA Oruka Therapeutics | $14.25
-3.1% | 5/22/2025 | Upgraded by | BTIG Research | Analyst J. Harrison | Strong-Buy | $44.00 | High | View details for BTIG Research rating of Oruka Therapeutics (NASDAQ:ORKA) on 5/22/2025 |
CLYM Climb Bio | $1.37
-3.5% | 5/22/2025 | Upgraded by | BTIG Research | Analyst J. Harrison | Strong-Buy | $7.00 | High | View details for BTIG Research rating of Climb Bio (NASDAQ:CLYM) on 5/22/2025 |
NFE New Fortress Energy | $3.76
-3.3% | 5/15/2025 | Target Set by | BTIG Research | Analyst Gregory Lewis | Buy -> Buy | $8.00 | High | View details for BTIG Research rating of New Fortress Energy (NASDAQ:NFE) on 5/15/2025 |
ESTA Establishment Labs | $44.42
-2.4% | 5/16/2025 | Initiated by | BTIG Research | - | Buy -> Buy | $62.00 | Medium | View details for BTIG Research rating of Establishment Labs (NASDAQ:ESTA) on 5/16/2025 |
BIRK Birkenstock | $46.47
-3.0% | 5/15/2025 | Target Raised by | BTIG Research | - | Buy | $70.00 -> $72.00 | Medium | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 5/15/2025 |
TOI Oncology Institute | $2.97
-7.5% | 5/15/2025 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $7.00 | High | View details for BTIG Research rating of Oncology Institute (NASDAQ:TOI) on 5/15/2025 |
EXOD Exodus Movement | $31.33
-7.0% | 5/12/2025 | Reiterated by | BTIG Research | Analyst A. Harte | Buy -> Buy | | N/A | View details for BTIG Research rating of Exodus Movement (NYSEAMERICAN:EXOD) on 5/12/2025 |
SMR NuScale Power | $42.90
+1.9% | 5/13/2025 | Reiterated by | BTIG Research | Analyst G. Lewis | Buy -> Buy | | Low | View details for BTIG Research rating of NuScale Power (NYSE:SMR) on 5/13/2025 |
ALC Alcon | $86.04
-1.5% | 5/14/2025 | Target Lowered by | BTIG Research | Analyst R. Zimmerman | Buy | $102.00 -> $99.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 5/14/2025 |
MSTR MicroStrategy | $442.31
-1.9% | 5/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 5/14/2025 |
EZPW EZCORP | $13.95
-1.8% | 5/14/2025 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | High | View details for BTIG Research rating of EZCORP (NASDAQ:EZPW) on 5/14/2025 |
AVDX AvidXchange | $9.84
| 5/7/2025 | Downgraded by | BTIG Research | Analyst A. Harte | Strong-Buy -> Hold | | Low | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 5/7/2025 |
DCGO DocGo | $1.39
-4.8% | 5/9/2025 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | High | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 5/9/2025 |
DH Definitive Healthcare | $3.95
-1.7% | 5/9/2025 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | High | View details for BTIG Research rating of Definitive Healthcare (NASDAQ:DH) on 5/9/2025 |
ESNT Essent Group | $55.70
-1.3% | 5/9/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Essent Group (NYSE:ESNT) on 5/9/2025 |
SDRL Seadrill | $28.86
-2.8% | 5/5/2025 | Target Set by | BTIG Research | Analyst Gregory Lewis | | $28.00 | High | View details for BTIG Research rating of Seadrill (NYSE:SDRL) on 5/5/2025 |
MASI Masimo | $160.04
-1.0% | 5/7/2025 | Target Set by | BTIG Research | Analyst Marie Thibault | Buy -> Buy | $193.00 | Medium | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 5/7/2025 |
DRS Leonardo DRS | $47.59
-0.8% | 5/5/2025 | Target Set by | BTIG Research | Analyst Andre Madrid | Buy -> Buy | $49.00 | Low | View details for BTIG Research rating of Leonardo DRS (NASDAQ:DRS) on 5/5/2025 |
RIG Transocean | $2.64
-3.8% | 5/5/2025 | Target Set by | BTIG Research | Analyst Gregory Lewis | Buy -> Buy | $5.00 | High | View details for BTIG Research rating of Transocean (NYSE:RIG) on 5/5/2025 |
HPP Hudson Pacific Properties | $2.77
-2.8% | 5/6/2025 | Target Set by | BTIG Research | Analyst Thomas Catherwood | Buy -> Buy | $8.00 | Medium | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 5/6/2025 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
DDOG Datadog | $140.56
+1.3% | 5/6/2025 | Target Set by | BTIG Research | Analyst Gray Powell | Buy -> Buy | $136.00 | Medium | View details for BTIG Research rating of Datadog (NASDAQ:DDOG) on 5/6/2025 |
XGN Exagen | $6.78
-4.1% | 5/7/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of Exagen (NASDAQ:XGN) on 5/7/2025 |
ADC Agree Realty | $71.67
-1.1% | 5/7/2025 | Downgraded by | BTIG Research | Analyst M. Gorman | Buy -> Neutral | | Low | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 5/7/2025 |
HWM Howmet Aerospace | $184.67
+0.2% | 5/5/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Medium | View details for BTIG Research rating of Howmet Aerospace (NYSE:HWM) on 5/5/2025 |
ARVN Arvinas | $7.40
-6.0% | 5/2/2025 | Target Set by | BTIG Research | Analyst J. Mukherjee | Buy -> Buy | $16.00 | High | View details for BTIG Research rating of Arvinas (NASDAQ:ARVN) on 5/2/2025 |
ATI ATI | $89.98
-0.7% | 5/5/2025 | Target Set by | BTIG Research | Analyst Andre Madrid | Buy -> Buy | $90.00 | Medium | View details for BTIG Research rating of ATI (NYSE:ATI) on 5/5/2025 |
ONIT Onity Group | $36.68
-2.0% | 5/5/2025 | Reiterated by | BTIG Research | Analyst E. Hagen | Buy -> Buy | | Low | View details for BTIG Research rating of Onity Group (NYSE:ONIT) on 5/5/2025 |
BILL BILL | $45.45
-1.8% | 4/30/2025 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $60.00 | Medium | View details for BTIG Research rating of BILL (NYSE:BILL) on 4/30/2025 |
INMD InMode | $14.25
-3.3% | 4/29/2025 | Downgraded by | BTIG Research | Analyst Sam Eiber | Buy -> Neutral | | Medium | View details for BTIG Research rating of InMode (NASDAQ:INMD) on 4/29/2025 |
DPZ Domino's Pizza | $465.39
-1.6% | 4/28/2025 | Target Set by | BTIG Research | - | Buy -> Buy | $530.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NASDAQ:DPZ) on 4/28/2025 |
IVT InvenTrust Properties | $26.83
-1.8% | 4/28/2025 | Initiated by | BTIG Research | Analyst M. Gorman | Buy | $31.00 | Medium | View details for BTIG Research rating of InvenTrust Properties (NYSE:IVT) on 4/28/2025 |
RITM Rithm Capital | $11.71
-0.2% | 4/25/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | $16.00 | Low | View details for BTIG Research rating of Rithm Capital (NYSE:RITM) on 4/25/2025 |
VFS VinFast Auto | $3.51
-0.8% | 4/25/2025 | Downgraded by | BTIG Research | Analyst Greg Lewis | Buy -> Neutral | | Medium | View details for BTIG Research rating of VinFast Auto (NASDAQ:VFS) on 4/25/2025 |
MCD McDonald's | $299.58
-0.8% | 4/22/2025 | Reiterated by | BTIG Research | - | Neutral -> Neutral | | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 4/22/2025 |
PEN Penumbra | $236.44
-1.2% | 4/24/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 4/24/2025 |
BSX Boston Scientific | $103.43
-0.9% | 4/23/2025 | Reiterated by | BTIG Research | Analyst Marie Thibault | Buy -> Buy | $124.00 | Medium | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 4/23/2025 |
ARI Apollo Commercial Real Estate Finance | $9.85
-1.4% | 4/23/2025 | Upgraded by | BTIG Research | Analyst T. Catherwood | Neutral -> Buy | $11.00 | Low | View details for BTIG Research rating of Apollo Commercial Real Estate Finance (NYSE:ARI) on 4/23/2025 |
GENI Genius Sports | $10.25
-0.7% | 4/22/2025 | Target Raised by | BTIG Research | Analyst Clark Lampen | Buy -> Buy | $11.00 -> $12.00 | High | View details for BTIG Research rating of Genius Sports (NYSE:GENI) on 4/22/2025 |
FLUT Flutter Entertainment | $293.58
-0.5% | 4/22/2025 | Target Lowered by | BTIG Research | Analyst Clark Lampen | Buy -> Buy | $323.00 -> $289.00 | High | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 4/22/2025 |
DKNG DraftKings | $43.80
+0.0% | 4/22/2025 | Target Lowered by | BTIG Research | Analyst Clark Lampen | Buy -> Buy | $64.00 -> $52.00 | Medium | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 4/22/2025 |
FOR Forestar Group | $22.18
-0.8% | 4/21/2025 | Target Lowered by | BTIG Research | Analyst Ryan Gilbert | Buy -> Buy | $36.00 -> $29.00 | Medium | View details for BTIG Research rating of Forestar Group (NYSE:FOR) on 4/21/2025 |
AXP American Express | $310.67
-3.2% | 4/21/2025 | Target Lowered by | BTIG Research | Analyst V. Caintic | Sell -> Sell | $272.00 -> $240.00 | Medium | View details for BTIG Research rating of American Express (NYSE:AXP) on 4/21/2025 |
TEM Tempus AI | $55.89
-3.3% | 4/21/2025 | Initiated by | BTIG Research | Analyst Mark Massaro | Buy -> Buy | $60.00 | High | View details for BTIG Research rating of Tempus AI (NASDAQ:TEM) on 4/21/2025 |
DHI D.R. Horton | $129.81
-4.6% | 4/16/2025 | Target Lowered by | BTIG Research | Analyst Carl Reichardt | Buy -> Buy | $171.00 -> $150.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2025 |
EOLS Evolus | $9.27
-2.5% | 4/17/2025 | Initiated by | BTIG Research | Analyst Sam Eiber | Buy | $21.00 | Medium | View details for BTIG Research rating of Evolus (NASDAQ:EOLS) on 4/17/2025 |
ISRG Intuitive Surgical | $512.23
-0.8% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $560.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/14/2025 |
SYK Stryker | $390.80
-0.2% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $403.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 4/14/2025 |
ICAD icad | $3.73
-2.4% | 4/16/2025 | Downgraded by | BTIG Research | Analyst M. Thibault | Buy -> Neutral | | Low | View details for BTIG Research rating of icad (NASDAQ:ICAD) on 4/16/2025 |
GEHC GE HealthCare Technologies | $74.39
-0.1% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $95.00 | Low | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 4/14/2025 |
TMHC Taylor Morrison Home | $62.16
-3.7% | 4/16/2025 | Target Set by | BTIG Research | Analyst Carl Reichardt | Buy -> Buy | $75.00 | High | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 4/16/2025 |
ZBH Zimmer Biomet | $93.99
+0.1% | 4/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 4/14/2025 |
AMTM Amentum | $23.79
-1.6% | 4/15/2025 | Initiated by | BTIG Research | Analyst Andre Madrid | Buy | $30.00 | Low | View details for BTIG Research rating of Amentum (NYSE:AMTM) on 4/15/2025 |
HUT Hut 8 | C$29.57
-2.4% | 4/14/2025 | Upgraded by | BTIG Research | Analyst G. Lewis | Strong-Buy | | N/A | View details for BTIG Research rating of Hut 8 (TSE:HUT) on 4/14/2025 |
HUT Hut 8 | $21.56
-2.5% | 4/14/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Buy | $18.00 | High | View details for BTIG Research rating of Hut 8 (NASDAQ:HUT) on 4/14/2025 |
SRAD Sportradar Group | $29.56
+1.0% | 4/11/2025 | Initiated by | BTIG Research | Analyst Clark Lampen | Buy | $28.00 | Low | View details for BTIG Research rating of Sportradar Group (NASDAQ:SRAD) on 4/11/2025 |
OKLO Oklo | $61.14
-2.0% | 4/11/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Neutral | | Low | View details for BTIG Research rating of Oklo (NYSE:OKLO) on 4/11/2025 |
SMR NuScale Power | $42.90
+1.9% | 4/11/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Buy | $20.00 | Low | View details for BTIG Research rating of NuScale Power (NYSE:SMR) on 4/11/2025 |
FOUR Shift4 Payments | $102.27
-1.0% | 4/10/2025 | Target Lowered by | BTIG Research | Analyst Hal Goetsch | Buy -> Buy | $135.00 -> $110.00 | Low | View details for BTIG Research rating of Shift4 Payments (NYSE:FOUR) on 4/10/2025 |
ALDX Aldeyra Therapeutics | $4.97
-0.8% | 4/7/2025 | Target Lowered by | BTIG Research | Analyst Thomas Shrader | Buy -> Buy | $11.00 -> $9.00 | High | View details for BTIG Research rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/7/2025 |
UPWK Upwork | $12.93
-0.2% | 4/4/2025 | Downgraded by | BTIG Research | Analyst Marvin Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 4/4/2025 |
BKNG Booking | $5,675.53
-1.6% | 4/4/2025 | Upgraded by | BTIG Research | Analyst Jake Fuller | Neutral -> Buy | $5,500.00 | High | View details for BTIG Research rating of Booking (NASDAQ:BKNG) on 4/4/2025 |
WING Wingstop | $317.66
-0.2% | 3/25/2025 | Reiterated by | BTIG Research | Analyst P. Saleh | Buy -> Buy | | High | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $3.11
-3.1% | 4/2/2025 | Initiated by | BTIG Research | Analyst Thomas Schrader | Buy | $18.00 | High | View details for BTIG Research rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/2/2025 |
PGNY Progyny | $23.24
-1.0% | 3/31/2025 | Upgraded by | BTIG Research | Analyst David Larsen | Neutral -> Buy | $28.00 | Medium | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 3/31/2025 |
LULU lululemon athletica | $222.19
-2.9% | 3/28/2025 | Target Lowered by | BTIG Research | - | Buy | $470.00 -> $420.00 | Medium | View details for BTIG Research rating of lululemon athletica (NASDAQ:LULU) on 3/28/2025 |
SGHC Super Group (SGHC) | $11.50
-1.3% | 3/28/2025 | Initiated by | BTIG Research | Analyst Clark Lampen | Buy | $9.00 | Medium | View details for BTIG Research rating of Super Group (SGHC) (NYSE:SGHC) on 3/28/2025 |
ATRC AtriCure | $30.54
-2.4% | 3/27/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 3/27/2025 |
LNSR LENSAR | $12.90
| 3/24/2025 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | Low | View details for BTIG Research rating of LENSAR (NASDAQ:LNSR) on 3/24/2025 |
LUCD Lucid Diagnostics | $1.17
| 3/25/2025 | Target Set by | BTIG Research | - | | $2.00 | Medium | View details for BTIG Research rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/25/2025 |
ALLY Ally Financial | $39.06
-3.9% | 3/25/2025 | Downgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Sell | $30.00 | Medium | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 3/25/2025 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
CRWD CrowdStrike | $473.28
-0.6% | 3/25/2025 | Upgraded by | BTIG Research | Analyst Gray Powell | Neutral -> Buy | $431.00 | Medium | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/25/2025 |
COF Capital One Financial | $215.48
-2.4% | 3/25/2025 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $208.00 | Low | View details for BTIG Research rating of Capital One Financial (NYSE:COF) on 3/25/2025 |
OVID Ovid Therapeutics | $0.37
-7.3% | 3/24/2025 | Target Lowered by | BTIG Research | Analyst Thomas Shrader | Buy -> Buy | $5.00 -> $4.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 3/24/2025 |
OBIO Orchestra BioMed | $2.92
-3.6% | 3/20/2025 | Initiated by | BTIG Research | Analyst Marie Thibault | Buy | $12.00 | High | View details for BTIG Research rating of Orchestra BioMed (NASDAQ:OBIO) on 3/20/2025 |
GBTG Global Business Travel Group | $6.27
-1.5% | 3/18/2025 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $10.00 | Low | View details for BTIG Research rating of Global Business Travel Group (NYSE:GBTG) on 3/18/2025 |
MXCT MaxCyte | $2.11
-5.8% | 3/12/2025 | Target Set by | BTIG Research | Analyst Mark Massaro | Buy -> Buy | $6.00 | High | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/12/2025 |
EXOD Exodus Movement | $31.33
-7.0% | 3/12/2025 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $40.00 | N/A | View details for BTIG Research rating of Exodus Movement (NYSEAMERICAN:EXOD) on 3/12/2025 |
SOPH SOPHiA GENETICS | $3.47
+0.3% | 3/6/2025 | Target Set by | BTIG Research | - | | $5.00 | High | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2025 |
ZS Zscaler | $288.90
-0.8% | 3/6/2025 | Target Set by | BTIG Research | - | Buy -> Buy | $252.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 3/6/2025 |
NTRA Natera | $149.85
-5.3% | 2/28/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 2/28/2025 |
OKTA Okta | $91.10
-0.9% | 3/4/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Medium | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 3/4/2025 |
PTGX Protagonist Therapeutics | $55.32
+0.2% | 3/3/2025 | Target Set by | BTIG Research | - | | $73.00 | High | View details for BTIG Research rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/3/2025 |
ARCT Arcturus Therapeutics | $13.15
-1.2% | 3/10/2025 | Target Set by | BTIG Research | Analyst T. Shrader | Buy -> Buy | $48.00 | Medium | View details for BTIG Research rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/10/2025 |
SAIL SailPoint | $20.36
-1.3% | 3/10/2025 | Initiated by | BTIG Research | Analyst G. Powell | Buy | $27.00 | N/A | View details for BTIG Research rating of SailPoint (NASDAQ:SAIL) on 3/10/2025 |
OPRT Oportun Financial | $6.49
| 3/5/2025 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $10.00 | High | View details for BTIG Research rating of Oportun Financial (NASDAQ:OPRT) on 3/5/2025 |
ARDX Ardelyx | $4.50
-2.4% | 3/4/2025 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $14.00 | High | View details for BTIG Research rating of Ardelyx (NASDAQ:ARDX) on 3/4/2025 |
NVAX Novavax | $6.88
-1.3% | 2/28/2025 | Initiated by | BTIG Research | Analyst T. Shrader | Buy | $19.00 | High | View details for BTIG Research rating of Novavax (NASDAQ:NVAX) on 2/28/2025 |
FLYW Flywire | $11.19
-0.7% | 2/26/2025 | Downgraded by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | High | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 2/26/2025 |
PYPL PayPal | $72.96
-1.3% | 2/4/2025 | Reiterated by | BTIG Research | - | Neutral -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 2/4/2025 |
CRS Carpenter Technology | $279.00
+0.2% | 1/31/2025 | Target Set by | BTIG Research | Analyst Andre Madrid | | $230.00 | High | View details for BTIG Research rating of Carpenter Technology (NYSE:CRS) on 1/31/2025 |
FLUT Flutter Entertainment | $293.58
-0.5% | 2/3/2025 | Target Set by | BTIG Research | Analyst Clark Lampen | | $323.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 2/3/2025 |
DKNG DraftKings | $43.80
+0.0% | 2/3/2025 | Target Set by | BTIG Research | Analyst Clark Lampen | | $59.00 | Medium | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 2/3/2025 |
SNOW Snowflake | $212.78
-0.3% | 2/20/2025 | Upgraded by | BTIG Research | Analyst G. Powell | Neutral -> Buy | $220.00 | Medium | View details for BTIG Research rating of Snowflake (NYSE:SNOW) on 2/20/2025 |
GD General Dynamics | $301.45
-1.1% | 2/13/2025 | Downgraded by | BTIG Research | Analyst A. Madrid | Buy -> Neutral | | High | View details for BTIG Research rating of General Dynamics (NYSE:GD) on 2/13/2025 |
STAA STAAR Surgical | $16.86
-2.5% | 2/12/2025 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 2/12/2025 |
ARR ARMOUR Residential REIT | $16.54
-1.2% | 2/10/2025 | Initiated by | BTIG Research | Analyst E. Hagen | Neutral | | Low | View details for BTIG Research rating of ARMOUR Residential REIT (NYSE:ARR) on 2/10/2025 |
KURA Kura Oncology | $6.13
-3.5% | 2/6/2025 | Downgraded by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | High | View details for BTIG Research rating of Kura Oncology (NASDAQ:KURA) on 2/6/2025 |
ENVA Enova International | $112.81
-2.5% | 2/5/2025 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $122.00 -> $129.00 | Low | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 2/5/2025 |
TMCI Treace Medical Concepts | $5.75
-4.0% | 2/4/2025 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $16.00 | High | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 2/4/2025 |
IQV IQVIA | $157.71
-1.5% | 2/3/2025 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | Medium | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/3/2025 |
MGM MGM Resorts International | $37.71
-1.1% | 2/3/2025 | Downgraded by | BTIG Research | Analyst C. Lampen | Buy -> Neutral | | Medium | View details for BTIG Research rating of MGM Resorts International (NYSE:MGM) on 2/3/2025 |
ARCT Arcturus Therapeutics | $13.15
-1.2% | 1/28/2025 | Initiated by | BTIG Research | Analyst Thomas Shrader | Buy | $41.00 | High | View details for BTIG Research rating of Arcturus Therapeutics (NASDAQ:ARCT) on 1/28/2025 |
AXP American Express | $310.67
-3.2% | 1/24/2025 | Target Raised by | BTIG Research | Analyst V. Caintic | Sell -> Sell | $266.00 -> $270.00 | High | View details for BTIG Research rating of American Express (NYSE:AXP) on 1/24/2025 |
PLD Prologis | $108.52
-0.8% | 1/17/2025 | Target Lowered by | BTIG Research | - | Buy -> Buy | $154.00 -> $134.00 | Medium | View details for BTIG Research rating of Prologis (NYSE:PLD) on 1/17/2025 |
MTCH Match Group | $31.87
-1.2% | 1/14/2025 | Downgraded by | BTIG Research | Analyst J. Fuller | Buy -> Neutral | | Medium | View details for BTIG Research rating of Match Group (NASDAQ:MTCH) on 1/14/2025 |
CART Maplebear | $48.67
+1.4% | 1/14/2025 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $58.00 | Medium | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 1/14/2025 |
BOOT Boot Barn | $163.34
-4.2% | 1/13/2025 | Target Raised by | BTIG Research | Analyst Janine Stichter | Buy -> Buy | $185.00 -> $190.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 1/13/2025 |
IBRX ImmunityBio | $2.74
-5.5% | 1/10/2025 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $6.00 | High | View details for BTIG Research rating of ImmunityBio (NASDAQ:IBRX) on 1/10/2025 |
PANW Palo Alto Networks | $192.25
+0.8% | 1/8/2025 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Medium | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 1/8/2025 |
HIMS Hims & Hers Health | $50.44
-3.1% | 1/7/2025 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $35.00 | Medium | View details for BTIG Research rating of Hims & Hers Health (NYSE:HIMS) on 1/7/2025 |
VSTM Verastem | $4.89
-1.4% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $20.00 | N/A | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 12/31/2024 |
FTAI FTAI Aviation | $113.79
-0.8% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $190.00 | N/A | View details for BTIG Research rating of FTAI Aviation (NASDAQ:FTAI) on 12/31/2024 |
SDA SunCar Technology Group | $2.41
| 12/30/2024 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $12.00 | N/A | View details for BTIG Research rating of SunCar Technology Group (NASDAQ:SDA) on 12/30/2024 |
IIPR Innovative Industrial Properties | $54.01
-3.9% | 12/23/2024 | Downgraded by | BTIG Research | Analyst T. Catherwood | Buy -> Neutral | | N/A | View details for BTIG Research rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2024 |
IREN IREN | $16.88
-2.3% | 12/20/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $33.00 | N/A | View details for BTIG Research rating of IREN (NASDAQ:IREN) on 12/20/2024 |
LEN Lennar | $107.80
-4.5% | 12/20/2024 | Downgraded by | BTIG Research | Analyst C. Reichardt | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lennar (NYSE:LEN) on 12/20/2024 |
FREY FREYR Battery | $1.40
+1.4% | 12/20/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $4.00 | N/A | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 12/20/2024 |
AVTX Avalo Therapeutics | $4.80
-2.0% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $40.00 | N/A | View details for BTIG Research rating of Avalo Therapeutics (NASDAQ:AVTX) on 12/19/2024 |
RNAC Cartesian Therapeutics | $13.58
+4.0% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $42.00 | N/A | View details for BTIG Research rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/19/2024 |
BIRK Birkenstock | $46.47
-3.0% | 12/18/2024 | Target Raised by | BTIG Research | Analyst J. Stichter | Buy | $60.00 -> $70.00 | N/A | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 12/18/2024 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
ADPT Adaptive Biotechnologies | $11.06
-4.2% | 12/18/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $9.00 | N/A | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 12/18/2024 |
REAX Real Brokerage | $3.95
-2.7% | 12/18/2024 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $6.00 | N/A | View details for BTIG Research rating of Real Brokerage (NASDAQ:REAX) on 12/18/2024 |
GTLS Chart Industries | $165.13
-0.8% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $170.00 -> $210.00 | N/A | View details for BTIG Research rating of Chart Industries (NYSE:GTLS) on 12/16/2024 |
BE Bloom Energy | $25.32
-2.5% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 12/16/2024 |
CORZ Core Scientific | $13.76
+1.5% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 12/16/2024 |
GAMB Gambling.com Group | $11.54
-1.3% | 12/13/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $19.00 | N/A | View details for BTIG Research rating of Gambling.com Group (NASDAQ:GAMB) on 12/13/2024 |
ELVN Enliven Therapeutics | $21.65
-5.9% | 12/13/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $42.00 | N/A | View details for BTIG Research rating of Enliven Therapeutics (NASDAQ:ELVN) on 12/13/2024 |
GMED Globus Medical | $55.86
-2.6% | 12/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $91.00 | N/A | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 12/12/2024 |
KROS Keros Therapeutics | $14.25
-2.2% | 12/12/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
AVDX AvidXchange | $9.84
| 12/11/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $14.00 | N/A | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/11/2024 |
NRIX Nurix Therapeutics | $12.15
-4.3% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $35.00 | N/A | View details for BTIG Research rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/10/2024 |
KYMR Kymera Therapeutics | $44.91
+0.0% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $60.00 | N/A | View details for BTIG Research rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/10/2024 |
ARVN Arvinas | $7.40
-6.0% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $69.00 | N/A | View details for BTIG Research rating of Arvinas (NASDAQ:ARVN) on 12/10/2024 |
CARM Carisma Therapeutics | $0.41
-9.1% | 12/10/2024 | Downgraded by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | N/A | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 12/10/2024 |
ONIT Onity Group | $36.68
-2.0% | 12/9/2024 | Upgraded by | BTIG Research | Analyst E. Hagen | Neutral -> Buy | $40.00 | N/A | View details for BTIG Research rating of Onity Group (NYSE:ONIT) on 12/9/2024 |
OKTA Okta | $91.10
-0.9% | 12/4/2024 | Target Raised by | BTIG Research | - | Buy | $98.00 -> $110.00 | N/A | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
JANX Janux Therapeutics | $25.76
-1.6% | 12/3/2024 | Target Raised by | BTIG Research | - | Buy | $82.00 -> $100.00 | N/A | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
EVH Evolent Health | $11.39
+0.3% | 12/3/2024 | Target Lowered by | BTIG Research | - | Buy | $36.00 -> $29.00 | N/A | View details for BTIG Research rating of Evolent Health (NYSE:EVH) on 12/3/2024 |
BV BrightView | $15.35
-2.5% | 12/2/2024 | Initiated by | BTIG Research | Analyst C. Reichardt | Buy | $22.00 | N/A | View details for BTIG Research rating of BrightView (NYSE:BV) on 12/2/2024 |
ANAB AnaptysBio | $26.63
-1.2% | 12/2/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 12/2/2024 |
OTLK Oncobiologics | $2.27
-2.2% | 11/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $9.00 | N/A | View details for BTIG Research rating of Oncobiologics (NASDAQ:OTLK) on 11/29/2024 |
REG Regency Centers | $68.62
-1.9% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $79.00 | N/A | View details for BTIG Research rating of Regency Centers (NASDAQ:REG) on 11/27/2024 |
CDP COPT Defense Properties | $27.80
-1.9% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $38.00 | N/A | View details for BTIG Research rating of COPT Defense Properties (NYSE:CDP) on 11/27/2024 |
ADC Agree Realty | $71.67
-1.1% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $74.00 -> $78.00 | N/A | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 11/27/2024 |
ZS Zscaler | $288.90
-0.8% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $205.00 -> $238.00 | N/A | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/27/2024 |
EMBC Embecta | $9.58
-7.6% | 11/27/2024 | Upgraded by | BTIG Research | Analyst M. Thibault | Neutral -> Buy | $26.00 | N/A | View details for BTIG Research rating of Embecta (NASDAQ:EMBC) on 11/27/2024 |
ALC Alcon | $86.04
-1.5% | 11/26/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 11/26/2024 |
ALEC Alector | $1.55
-7.2% | 11/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $16.00 -> $5.00 | N/A | View details for BTIG Research rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
ISRG Intuitive Surgical | $512.23
-0.8% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $535.00 -> $561.00 | N/A | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 11/26/2024 |
GKOS Glaukos | $98.34
-5.6% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $149.00 | N/A | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 11/26/2024 |
PEN Penumbra | $236.44
-1.2% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $232.00 -> $270.00 | N/A | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 11/26/2024 |
VCEL Vericel | $37.10
-6.8% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $66.00 | N/A | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 11/26/2024 |
EXAS Exact Sciences | $52.99
-2.4% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $75.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/26/2024 |
VVX V2X | $46.70
-4.5% | 11/25/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $80.00 | N/A | View details for BTIG Research rating of V2X (NYSE:VVX) on 11/25/2024 |
PANW Palo Alto Networks | $192.25
+0.8% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $197.50 -> $207.00 | N/A | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
MSTR MicroStrategy | $442.31
-1.9% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $290.00 -> $570.00 | N/A | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 11/21/2024 |
ACRS Aclaris Therapeutics | $1.52
-3.8% | 11/19/2024 | Upgraded by | BTIG Research | Analyst J. Harrison | Neutral -> Buy | $8.00 | N/A | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024 |
VYNE VYNE Therapeutics | $1.29
-3.0% | 11/18/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $8.00 | N/A | View details for BTIG Research rating of VYNE Therapeutics (NASDAQ:VYNE) on 11/18/2024 |
BE Bloom Energy | $25.32
-2.5% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $16.00 -> $20.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 11/15/2024 |
CIFR Cipher Mining | $5.97
-1.0% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $6.00 -> $9.00 | N/A | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 11/15/2024 |
CORZ Core Scientific | $13.76
+1.5% | 11/15/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $15.00 -> $19.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 11/15/2024 |
HQY HealthEquity | $96.18
-1.2% | 11/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 11/14/2024 |
PLUG Plug Power | $1.53
-2.5% | 11/14/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | N/A | View details for BTIG Research rating of Plug Power (NASDAQ:PLUG) on 11/14/2024 |
ONON ON | $53.45
+0.4% | 11/13/2024 | Upgraded by | BTIG Research | Analyst J. Stichter | Neutral -> Buy | $64.00 | N/A | View details for BTIG Research rating of ON (NYSE:ONON) on 11/13/2024 |
ATLC Atlanticus | $53.81
-2.9% | 11/12/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $45.00 -> $54.00 | N/A | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 11/12/2024 |
VEL Velocity Financial | $17.67
-2.8% | 11/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $23.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 11/12/2024 |
CCSI Consensus Cloud Solutions | $19.83
-8.7% | 11/11/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $30.00 -> $32.00 | N/A | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/11/2024 |
FLUT Flutter Entertainment | $293.58
-0.5% | 11/11/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $249.00 -> $305.00 | N/A | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 11/11/2024 |
UPST Upstart | $74.13
-1.1% | 11/11/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Sell -> Neutral | | N/A | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 11/11/2024 |
EXPE Expedia Group | $178.99
-2.5% | 11/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $200.00 | N/A | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
PODD Insulet | $289.99
-0.7% | 11/8/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $260.00 -> $270.00 | N/A | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 11/8/2024 |
APP AppLovin | $352.96
-0.8% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $202.00 -> $291.00 | N/A | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
UPWK Upwork | $12.93
-0.2% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $16.00 | N/A | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 11/7/2024 |
MELI MercadoLibre | $2,390.00
+0.4% | 11/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $2,250.00 -> $2,200.00 | N/A | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
RVLV Revolve Group | $20.95
-2.1% | 11/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 11/6/2024 |
EXAS Exact Sciences | $52.99
-2.4% | 11/6/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $82.00 -> $65.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/6/2024 |
CDNA CareDx | $19.01
-5.0% | 11/5/2024 | Target Lowered by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $40.00 -> $35.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 11/5/2024 |
TCMD Tactile Systems Technology | $9.66
-3.8% | 11/5/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of Tactile Systems Technology (NASDAQ:TCMD) on 11/5/2024 |
FVRR Fiverr International | $26.26
-2.8% | 11/4/2024 | Downgraded by | BTIG Research | Analyst M. Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 11/4/2024 |
WRBY Warby Parker | $22.92
-0.4% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 11/1/2024 |
